452 related articles for article (PubMed ID: 22372502)
1. Advances in biomarker research for pancreatic cancer.
Bhat K; Wang F; Ma Q; Li Q; Mallik S; Hsieh TC; Wu E
Curr Pharm Des; 2012; 18(17):2439-51. PubMed ID: 22372502
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
Kriz D; Ansari D; Andersson R
Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
4. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
[TBL] [Abstract][Full Text] [Related]
5. Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?
Boeck S; Schulz C; Stieber P; Holdenrieder S; Weckbach S; Heinemann V
Onkologie; 2007 Feb; 30(1-2):39-42. PubMed ID: 17264524
[TBL] [Abstract][Full Text] [Related]
6. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Dittmar RL; Liu S; Tai MC; Rajapakshe K; Huang Y; Longton G; DeCapite C; Hurd MW; Paris PL; Kirkwood KS; Coarfa C; Maitra A; Brand RE; Killary AM; Sen S
Cancer Prev Res (Phila); 2021 Jul; 14(7):729-740. PubMed ID: 33893071
[TBL] [Abstract][Full Text] [Related]
7. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
8. Strategies for early detection of resectable pancreatic cancer.
Okano K; Suzuki Y
World J Gastroenterol; 2014 Aug; 20(32):11230-40. PubMed ID: 25170207
[TBL] [Abstract][Full Text] [Related]
9. Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
[TBL] [Abstract][Full Text] [Related]
10. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
12. Identification of miR-601 as a novel regulator in the development of pancreatic cancer.
Cao W; Jin H; Zhang L; Chen X; Qian H
Biochem Biophys Res Commun; 2017 Jan; 483(1):638-644. PubMed ID: 27993677
[TBL] [Abstract][Full Text] [Related]
13. MiRNAs as biomarkers of high-risk pancreatic cysts: a possible holy grail for the early detection of pancreatic cancer.
Permuth JB; Georgeades C; Malafa M
Future Oncol; 2015; 11(23):3105-8. PubMed ID: 26549701
[No Abstract] [Full Text] [Related]
14. Diagnostic biomarkers for pancreatic cancer: An update.
Yang M; Zhang CY
World J Gastroenterol; 2021 Dec; 27(45):7862-7865. PubMed ID: 34963749
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for early diagnosis of pancreatic cancer.
Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
18. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
Fukushige S; Horii A
Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
[TBL] [Abstract][Full Text] [Related]
19. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F
Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236
[TBL] [Abstract][Full Text] [Related]
20. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]